Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

astrazeneca cover image
$599
 Posted in: SGLT2i Mar 30 | 2020DAPA-CKD Stopped Early for Overwhelming EfficacyPurchase Blast
$599
 Posted in: GLP-1RA Mar 27 | 2020FENIX Analysis: Ozempic and Trulicity CV Indication Initial PromotionPurchase Blast
senseonics cover image
$599
 Posted in: Glucose Monitoring Mar 26 | 2020Senseonics Suspends US Commercial Sales to New PatientsPurchase Blast
$599
 Posted in: Other Mar 25 | 2020AZ Partners with Silence Therapeutics for siRNA Targeting; AZ Leverages BrightInsight for Digital PlatformPurchase Blast
$599
 Posted in: Glucose Monitoring Mar 24 | 2020DarioHealth Partners with Vitality GroupPurchase Blast
senseonics cover image
$599
 Posted in: Glucose Monitoring Mar 23 | 2020Senseonics Exploring Strategic AlternativesPurchase Blast
zealand cover image
$599
 Posted in: Dual/triple agonist, Other Mar 23 | 2020BI Returns Amylin Analog WW Rights to ZealandPurchase Blast
european medicines agency cover image
$599
 Posted in: Bolus Insulin, GLP-1RA Mar 23 | 2020CHMP Agenda March 23-26; Lilly Halts Trial Enrollments Over COVID-19 ConcernsPurchase Blast
BI and lilly cover image
$599
 Posted in: SGLT2i Mar 22 | 2020CRL for Empa 2.5mg in T1DMPurchase Blast
$599
 Posted in: Glucagon, Insulin Delivery, Other Mar 20 | 2020Glooko Enables Free Remote Care Solution; Hovorka’s AP App Launched in UK; Valeritas Receives Court Approval on Zealand SalePurchase Blast
lexicon cover image
$599
 Posted in: SGLT2i Mar 20 | 2020Thoughts on Lexicon Closing Its Sota CVOTsPurchase Blast
$599
 Posted in: Bolus Insulin, Glucagon Mar 19 | 2020Xeris Home Delivery via Amazon; Oramed End-of-Ph2 FDA FeedbackPurchase Blast
medtronic cover image
$599
 Posted in: Other Mar 18 | 2020Medtronic To Move Away From Its Non-Intensive Diabetes StrategyPurchase Blast
$599
 Posted in: Glucose Monitoring Mar 18 | 2020Nemaura to Use Wellness Category for US CGM LaunchPurchase Blast
$599
 Posted in: Glucose Monitoring, Other Mar 17 | 2020DarioHealth Q4 '19 Earnings UpdatePurchase Blast
$599
 Posted in: DPP-IVi, Other Mar 17 | 2020Mylan/Aurobindo Invalidates Two Tradjenta Patents; PRV-031 (Teplizumab) Ph3 PROTECT Trial PausedPurchase Blast
pfizer cover image
$599
 Posted in: GLP-1RA Mar 16 | 2020New Pfizer Oral GLP-1RA Compound in Ph1Purchase Blast
$599
 Posted in: GLP-1RA Mar 13 | 2020Thoughts on Intarcia’s Second CRLPurchase Blast
senseonics cover image
$599
 Posted in: Glucose Monitoring Mar 12 | 2020Senseonics Q4 '19 Earnings UpdatePurchase Blast
zealand cover image
$599
 Posted in: Glucagon Mar 12 | 2020Zealand Q4 ’19 Earnings UpdatePurchase Blast
1 … 51 52 53 54 55 … 88

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.

Contact BradyLog In